Technical Articles

凝血因子XI缺乏症的分子病理与靶向治疗新进展
Molecular Pathology and New Advances in Targeted Therapy for Factor XI Deficiency
发布时间 2026-08-04
This article systematically elaborates on the discovery history, molecular genetic basis, and unique clinical manifestations of coagulation factor XI deficiency (hemophilia C), analyzing the pathological puzzle of its lack of correlation between bleeding tendency and FXI levels as an autosomal recessive genetic disorder.
View details
  • Drug Research
  • Fully Human Anti-Factor XI Monoclonal Antibody
  • Abelacimab
Total 1
  • 1
Go to